The Department of Defense (DoD) is seeking proposals for the development of a rapid diagnostic for invasive fungal infection (IFI) in military treatment facilities or lower levels of care within 24 hours. IFIs are associated with significant morbidity and mortality, and early identification and treatment are crucial. Current diagnostic methods are often delayed and insensitive, requiring clinical and microbiological expertise. The DoD is looking for a technology that can quickly and accurately diagnose the presence of a wound-IFI, determine the causative agent, and potentially determine antifungal drug susceptibility. The technology should be easy to use, require minimal training, and be compatible with wet/dry environments and long-term storage. The project will have a Phase I focused on system design and development of proof-of-concept prototypes, followed by a Phase II for further refinement and optimization. The ultimate goal is to secure FDA approval and commercialize the technology, with potential applications in both civilian and military settings. The project duration and funding specifics are not provided in the document. For more information, visit the SBIR topic link or the solicitation agency website.